Roivant Sciences (ROIV) Profit After Tax (2020 - 2025)
Roivant Sciences (ROIV) reported Profit After Tax of -$313.7 million for Q4 2025, down 99.0% on a YoY basis from -$31.4 billion in Q4 2024, and down 88.93% quarter-over-quarter from -$166.0 million in Q3 2025.
Roivant Sciences (ROIV) Profit After Tax (2020 - 2025) Analysis & Trends
Roivant Sciences has reported Profit After Tax for 6 years, with the latest figure at -$313.7 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 99.0% year-over-year to -$313.7 million; the trailing twelve-month figure through Dec 2025 stood at -$911.3 million (down 119.42% YoY), and the FY2026 full-year result was -$299.8 million, up 45.01% from the prior year.
- Profit After Tax for Q4 2025 stood at -$313.7 million, down from -$166.0 million in the prior quarter.
- The five-year high for Profit After Tax was $5.1 billion in Q4 2023, with the low at -$384.9 million in Q4 2022.
- Historically, Profit After Tax has averaged $107.6 million across 5 years, with a median of -$279.9 million in 2024.
- Annual changes were most pronounced in 2021 — Profit After Tax tumbled 1167.12% — and 2023, when it surged 1417.93%.
- Roivant Sciences' Profit After Tax stood at -$284.5 million in 2021, then plunged by 35.27% to -$384.9 million in 2022, then surged by 1417.93% to $5.1 billion in 2023, then slumped by 103.11% to -$157.6 million in 2024, then slumped by 99.0% to -$313.7 million in 2025.
- The last three Profit After Tax figures came in at -$313.7 million (Q4 2025), -$166.0 million (Q3 2025), and -$273.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -313.70 Mn |
| Sep 30, 2025 | -166.04 Mn |
| Jun 30, 2025 | -273.91 Mn |
| Dec 31, 2024 | -157.64 Mn |
| Sep 30, 2024 | -279.92 Mn |
| Jun 30, 2024 | 57.49 Mn |
| Dec 31, 2023 | 5.07 Bn |
| Sep 30, 2023 | -331.12 Mn |
| Jun 30, 2023 | -327.85 Mn |
| Dec 31, 2022 | -384.90 Mn |
| Sep 30, 2022 | -315.92 Mn |
| Jun 30, 2022 | -353.78 Mn |
| Dec 31, 2021 | -284.54 Mn |
| Sep 30, 2021 | -225.64 Mn |
| Jun 30, 2021 | -101.08 Mn |
| Dec 31, 2020 | -275.60 Mn |
| Sep 30, 2020 | -53.50 Mn |
| Jun 30, 2020 | -7.98 Mn |